Hepatitis B vaccination

BIOLOGICAL5 trials

Sponsors

Kyoto University, VBI Vaccines Inc., Tel-Aviv Sourasky Medical Center, CyTuVax BV

Conditions

Chronic hepatitis BHepatitis B VaccinesImmune Hepatitisnon-responsiveness to hepatitis B

Phase 2

Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non-responders

Active, not recruitingNL-OMON47410

CyTuVax BVnon-responsiveness to hepatitis B

Start: 2017-03-08Target: 50Updated: 2024-02-28

Phase 3

Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults

CompletedNCT03393754

VBI Vaccines Inc.Hepatitis B Vaccines

Start: 2017-12-13End: 2019-04-08Updated: 2020-07-17

Lot-to-lot Consistency of Sci-B-Vac™ in Adults

CompletedNCT03408730

VBI Vaccines Inc.Hepatitis B Vaccines

Start: 2017-12-14End: 2019-10-01Updated: 2021-03-25

Unknown Phase

Hepatitis B vaccination for patients with chronic hepatitis B

RecruitingJPRN-UMIN000005978

Kyoto UniversityChronic hepatitis B

Start: 2011-08-01Target: 20Updated: 2025-07-18

Characterization of the Relationship Between the Human Mesolimbic Reward System and Immune Functioning

CompletedNCT03951870

Tel-Aviv Sourasky Medical CenterImmune Hepatitis

Start: 2019-01-20End: 2022-08-28Updated: 2022-09-22

Related Papers

Upregulation of reward mesolimbic activity and immune response to vaccination: a randomized controlled trial.

2026-01-19

A three antigen hepatitis B vaccine induces T cells to Pres1 and Pres2 which correlate with anti HBs antibody titers: An investigation into the immunological mechanisms contributing to high anti-HBs titers.

2024-11-12

Cost-effectiveness of a 3-antigen versus single-antigen vaccine for the prevention of hepatitis B in adults in the United States

Vaccine2023-05-014 citations

Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine

JAMA Network Open2021-10-1259 citations

Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial.

2021-05-1152 citations

LB13. Trivalent Hepatitis B (HepB) Vaccine Yields Superior Seroprotection Rates in Adults: Results from the Phase 3 Double-Blind, Randomized Study Comparing Immunogenicity and Safety of a 3-Dose Regimen of Sci-B-Vac™ and Engerix B® (PROTECT)

Open Forum Infectious Diseases2019-10-011 citations